BiotechTube
Home/Sporos Biodiscovery/Rachel Humphrey, M.D.
RH

Rachel Humphrey, M.D.

Board Member, CEO of Normunity

Sporos Biodiscovery

Therapeutic Areas

Oncology

Sporos Biodiscovery Pipeline

DrugIndicationPhase
SPR1Cancers with Hippo-driver mutations/aberrations & YAP/TAZ hyperactivationIND Enabling
SPR2Cancers resistant to immunotherapyDiscovery in Vitro
SPR3Cancers resistant to MAPK inhibition and/or immunotherapyDiscovery in Vitro
SPR4PTEN-deficient cancersDiscovery in Vitro

Leadership Team at Sporos Biodiscovery

SR
Stephen Rubino, Ph.D.
President
SS
Sharon Shacham, Ph.D.
Consulting Lead Scientist
FM
Florian Muller, Ph.D.
Cancer Biology
AC
Alex Cranberg, M.B.A.
Board Member, Chairman & Founder of Aspect Energy
View full Sporos Biodiscovery profile